Porvair (LON:PRV) Stock Rating Reaffirmed as “Buy” by Deutsche Bank Aktiengesellschaft

Porvair (LON:PRV – Get Free Report)‘s stock had its “buy” rating reissued by analysts at Deutsche Bank Aktiengesellschaft in a research report issued to clients and investors on Thursday, Digital Look reports. They currently have a GBX 1,050 price objective on the stock. Deutsche Bank Aktiengesellschaft’s price target points to a potential upside of 18.38% from the stock’s previous close.

Separately, Berenberg Bank dropped their price target on Porvair from GBX 1,050 to GBX 1,000 and set a “buy” rating on the stock in a research note on Thursday. Two research analysts have rated the stock with a Buy rating and one has given a Hold rating to the company’s stock. According to data from MarketBeat, Porvair has an average rating of “Moderate Buy” and a consensus target price of GBX 1,025.

Read Our Latest Stock Analysis on PRV

Porvair Stock Performance

Shares of LON PRV opened at GBX 887 on Thursday. The company has a current ratio of 1.94, a quick ratio of 1.22 and a debt-to-equity ratio of 14.49. Porvair has a 12 month low of GBX 678.82 and a 12 month high of GBX 938. The stock has a 50 day moving average of GBX 871.79 and a 200-day moving average of GBX 817.01. The company has a market capitalization of £409.84 million, a P/E ratio of 21.96 and a beta of 0.52.

Porvair Company Profile

(Get Free Report)

Porvair plc engages in the filtration, laboratory, and environmental technology business. It operates through three segments: Aerospace & Industrial, Laboratory, and Metal Melt Quality. The Aerospace & Industrial segment designs and manufactures a range of specialist filtration equipment for aerospace, energy, and industrial applications. The Laboratory segment is involved in the design and manufacture of instruments and consumables for use in environmental and bioscience laboratories with a focus on water analysis instruments, diagnostics, and sample preparation equipment.

See Also

Receive News & Ratings for Porvair Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Porvair and related companies with MarketBeat.com's FREE daily email newsletter.